Patients With PD, Mild Cognitive Impairment See Benefit From Transcranial Magnetic Stimulation

Patients With PD, Mild Cognitive Impairment See Benefit From Transcranial Magnetic Stimulation

Publication date: Oct 08, 2019

Noninvasive transcranial magnetic stimulation (TMS) may help improve cognitive performance in patients with Parkinson disease (PD) and mild cognitive impairment, according to a recent study.

Noninvasive transcranial magnetic stimulation (TMS) may help improve cognitive performance in patients with Parkinson disease (PD) and mild cognitive impairment, according to a recent study The preliminary findings from this study with 28 patients suggest that the intervention might improve overall cognitive performance in patients with PD with mild cognitive impairment for as long as 1 month. PD is the second most frequent neurodegenerative disease, with symptoms consisting of motor deficits caused by the loss of dopaminergic neurons in the substantia nigra pars compacta.

Two studies of TMS previous transcranial magnetic stimulation studies over the left DLPFC showed short-term improvement in cognitive performance and focused on specific task. The researchers in this study used intermittent theta burst stimulation (iTBS) over the left DLPFC, which another study reported is best suited for enhancing executive function in patients with medication-resistant depression.

Concepts Keywords
Anxiety Dementia
Apathy Mild cognitive impairment
Beck Depression Inventory Transcranial magnetic stimulation
Caudate Nucleus Dorsolateral prefrontal cortex
Cognition Learning disabilities
Cognitive Electrotherapy
Cognitive Impairment RTT
Dementia Cognitive disorders
Depression Psychiatric diagnosis
Dopaminergic Branches of biology
Dorsolateral Prefrontal Cortex Neuroscience
Executive Function Psychiatry
Hallucinations Frequent neurodegenerative disease
Memory Medication resistant depression
Mild Cognitive Impairment Active
Movement Disorders
Neurodegenerative Disease
Neurons
Neuropsychological Tests
Parkinson
Parkinsonism
Transcranial Magnetic Stimulation
Visuospatial
Working Memory

Semantics

Type Source Name
disease MESH Mild Cognitive Impairment
drug DRUGBANK Tilmicosin
disease MESH Parkinson disease
disease DOID Parkinson disease
disease MESH neurodegenerative disease
disease DOID neurodegenerative disease
disease MESH depression
disease MESH anxiety
disease DOID anxiety
disease MESH hallucinations
disease MESH dementia
disease DOID dementia
gene UNIPROT KCNK3
disease MESH Movement Disorders
disease MESH Apathy
disease MESH men
disease MESH separated
gene UNIPROT DESI1
gene UNIPROT SLC35G1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *